Visual effects in anaplastic lymphoma kinase ( ALK )-positive advanced non-small cell lung cancer (NSCLC) patients treated with crizotinib.
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: University of Chicago, Peter MacCallum Cancer Centre, Peter MacCallum Cancer Foundation, Massachusetts General Hospital, University of Colorado Cancer Center, Abramson Cancer Center, University of Pennsylvania, Seoul National University, Seoul National University Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, National Cancer Center, National Cancer Center Hospital, European Institute of Oncology, University of California, Irvine, Pfizer (United States)
Language: English
Topic: Drug-Induced Ocular Toxicity
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2592310381